The well‐described transgenic rTg4510 mice model, overexpressing the human 0N4R P301L mutated tau variant associated with frontotemporal dementia and parkinsonism, displays a large number of disease‐associated tau phosphorylations in the brain already at young age (52, 57, 62). The gene discussed is MAPT; the disease is Parkinsonism.